SRDX Stock Down Despite FDA Clearance for Pounce XL System
SRDXSurmodics(SRDX) ZACKS·2024-10-02 23:35

Surmodics, Inc. (SRDX) received the FDA's 510(k) clearance for its Pounce XL Thrombectomy System yesterday. Following the regulatory clearance, the Pounce Thrombectomy Platform can now likely be used to remove clots from peripheral arteries ranging from 2mm to 10 mm in diameter. Surmodics expects to initiate a limited market release for the Pounce XL Thrombectomy System in the first half of 2025, with commercialization planned following the completion of the limited market release. The latest FDA approval f ...